What is Truemeds?
Truemeds is a technology-driven tele-health platform dedicated to making healthcare affordable and accessible across India. By leveraging a proprietary algorithm and tele-consultation services, Truemeds aims to reduce healthcare expenses and improve patient outcomes. The platform achieves this by democratizing medicine purchases, recommending best-value medications through precise scientific matching and outcome history, leading to substantial savings for customers, reportedly up to 51%. This innovative approach positions Truemeds as a key player in India's rapidly evolving healthcare landscape, addressing critical needs for cost-effective and convenient medical solutions.
How much funding has Truemeds raised?
Truemeds has raised a total of $112M across 3 funding rounds:
Series A
$5M
Series B
$22M
Series C
$85M
Series A (2021): $5M with participation from InfoEdge Ventures, Asha Impact, and Indian Angel Network
Series B (2022): $22M led by Asha Impact, Westbridge Capital, and InfoEdge Ventures
Series C (2025): $85M supported by Accel, Peak XV Partners, Westbridge Capital Us Advisors, and Info Edge Ventures
Key Investors in Truemeds
Accel
Accel is a global venture capital firm that partners with exceptional teams from the inception of their ideas through all phases of private company growth, focusing on supporting innovative companies and entrepreneurs to scale and succeed.
Peak XV Partners
Peak XV Partners is a venture capital firm specializing in early-stage and growth-stage technology companies across Asia, providing capital investment and strategic support to help founders build scalable businesses.
Westbridge Capital Us Advisors
WestBridge Capital is an investment firm that supports Indian entrepreneurs with purpose-driven capital, focusing on long-term growth and sustainable solutions across various sectors including healthtech.
What's next for Truemeds?
With substantial backing from prominent investors, Truemeds is poised for accelerated growth and market penetration. The recent major strategic investment signals strong confidence in the company's business model and its potential to scale its operations. This capital infusion will likely be directed towards enhancing its technological infrastructure, expanding its service offerings, and strengthening its market presence within India. The company's focus on affordability and accessibility in healthcare aligns with significant market demands, suggesting a strategic trajectory aimed at capturing a larger share of the digital health market and solidifying its position as a leader in tele-health solutions.
See full Truemeds company page
